Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
The Home Depot, Inc. (HD) - free report >>
Five Below, Inc. (FIVE) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Home Depot, Inc. (HD) - free report >>
Five Below, Inc. (FIVE) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 29th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 29th:
Home Depot, Inc. (HD - Free Report) : This home improvement retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.
Home Depot, Inc. (The) Price and Consensus
Home Depot, Inc. (The) Price and Consensus | Home Depot, Inc. (The) Quote
Home Depot’s shares gained 2.2% over the last one month in contrast to S&P 500’s loss of 1.1%. The company possesses a Momentum Score of A.
Home Depot, Inc. (The) Price
Home Depot, Inc. (The) Price | Home Depot, Inc. (The) Quote
Corcept Therapeutics Incorporated (CORT - Free Report) : This pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 61.5% over the last 60 days.
Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus | Corcept Therapeutics Incorporated Quote
Corcept Therapeutics’ shares gained 20.7% over the last one month. The company possesses a Momentum Score of A.
Corcept Therapeutics Incorporated Price
Corcept Therapeutics Incorporated Price | Corcept Therapeutics Incorporated Quote
Five Below, Inc. (FIVE - Free Report) : This specialty value retailerhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.
Five Below, Inc. Price and Consensus
Five Below, Inc. Price and Consensus | Five Below, Inc. Quote
Five Below’s shares gained 4.9% over the last one month. The company possesses a Momentum Score of A.
Five Below, Inc. Price
Five Below, Inc. Price | Five Below, Inc. Quote
Taseko Mines Limited (TGB - Free Report) : This mining companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Taseko Mines Limited Price and Consensus
Taseko Mines Limited Price and Consensus | Taseko Mines Limited Quote
Taseko Mines’ shares gained 22.8% over the last one month. The company possesses a Momentum Score of A.
Taseko Mines Limited Price
Taseko Mines Limited Price | Taseko Mines Limited Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks' 10-Minute Stock-Picking Secret
Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.
But here's something even more remarkable: You can master this proven system without going to a single class or seminar. And then you can apply it to your portfolio in as little as 10 minutes a month. Learn the secret >>